About
Pulmonary drug delivery
Areas of Focus
Categories
Drug Delivery & FormulationBiotech
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
230
By Phase
PHASE3: 1PHASE2: 1
By Status
TERMINATED: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05039359Lead Sponsor
Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation
PHASE3Terminated
54 participants
Started: Apr 26, 2022 · Completed: May 22, 2023
NCT03539302Lead Sponsor
INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT)
PHASE2Completed
176 participants
Started: May 29, 2018 · Completed: Jan 17, 2022
Locations (1)
Headquarters
Newark, CA, United States
Map
Loading map...